ferrous bisglycinate

Small moleculeexperimental

Clinical trial activity

5 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1

Earliest trial started Apr 1, 2014 (NCT02128971)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetOTHER

    Supplement

  • IronSupplementation

    Iron supplementation

Chemistry & pharmacology

Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ferric glycinate
  • ferrous bisglycinate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06014983N/AOct 31, 2023University of British Columbia
NCT04017598Phase 4Jul 31, 2019Government of Cambodia, Helen Keller International, University of British Columbia
NCT03754543N/AJan 31, 2019Nestle, Swiss Federal Institute of Technology, University of Malawi
NCT02993835N/ADec 31, 2016Nestle
NCT02128971Phase 2Apr 1, 2014Albion, Sprim Consulting, University of Indonesia
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
NestleFor profit2212016
University of British ColumbiaAcademic/Hospital2222019
AlbionFor profit1112014
Government of CambodiaGovernment1012019
Helen Keller InternationalAcademic/Hospital1012019
Sprim ConsultingFor profit1012014
Swiss Federal Institute of TechnologyAcademic/Hospital1012019
University of IndonesiaAcademic/Hospital1012014
University of MalawiAcademic/Hospital1012019
9 organizations
Page 1 / 1